14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $189.44 $218.26 Wednesday, 24th Apr 2024 BIIB stock ended at $201.99. This is 4.56% more than the trading day before Tuesday, 23rd Apr 2024. During the day the stock fluctuated 3.41% from a day low at $198.97 to a day high of $205.75.
90 days $189.44 $251.99
52 weeks $189.44 $319.76

Historical Biogen Inc. prices

Date Open High Low Close Volume
Oct 24, 2023 $253.42 $255.53 $249.41 $252.11 764 645
Oct 23, 2023 $256.34 $256.34 $251.88 $253.39 943 107
Oct 20, 2023 $258.01 $260.50 $255.46 $257.45 1 807 368
Oct 19, 2023 $263.45 $263.45 $256.10 $257.30 1 095 083
Oct 18, 2023 $266.68 $268.15 $263.31 $263.50 945 517
Oct 17, 2023 $268.11 $269.43 $265.73 $267.43 614 997
Oct 16, 2023 $262.04 $268.73 $261.22 $267.94 1 223 789
Oct 13, 2023 $261.18 $262.35 $258.81 $262.26 840 785
Oct 12, 2023 $266.92 $268.00 $259.39 $260.99 1 258 601
Oct 11, 2023 $265.60 $268.41 $264.88 $266.52 774 839
Oct 10, 2023 $264.48 $265.15 $262.76 $264.14 689 921
Oct 09, 2023 $262.98 $264.89 $260.02 $264.21 611 357
Oct 06, 2023 $259.50 $265.18 $258.81 $263.25 1 058 026
Oct 05, 2023 $258.00 $260.14 $255.65 $259.77 806 312
Oct 04, 2023 $252.13 $257.55 $251.54 $257.16 1 004 144
Oct 03, 2023 $251.95 $253.75 $248.42 $251.31 817 872
Oct 02, 2023 $255.85 $256.86 $251.08 $252.86 710 699
Sep 29, 2023 $258.53 $259.23 $255.25 $257.01 846 540
Sep 28, 2023 $258.48 $259.35 $256.25 $257.83 631 624
Sep 27, 2023 $258.44 $261.38 $255.16 $257.52 753 280
Sep 26, 2023 $254.97 $258.46 $254.04 $258.05 810 535
Sep 25, 2023 $257.10 $257.10 $251.85 $255.02 718 357
Sep 22, 2023 $259.33 $260.72 $257.14 $257.68 784 354
Sep 20, 2023 $257.32 $262.48 $256.42 $260.53 1 097 379
Sep 19, 2023 $253.66 $256.80 $253.33 $256.67 480 381
Click to get the best stock tips daily for free!

About Biogen Inc.

Biogen. Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an etanercept biosimilar referencing ENBREL; ADUHELM for the treatment of Alzheimer's disease; IMRALDI, an ad... BIIB Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT